Literature DB >> 17890027

Recent advances in cell-penetrating, non-peptide molecular carriers.

Sung-Kee Chung1, Kaustabh K Maiti, Woo Sirl Lee.   

Abstract

The intracellular delivery of proteins and other bioactive molecules by employing membrane-permeable carrier peptide vectors, e.g. HIV-1 Tat, Antp-HD, and related arginine-rich peptides are well known for a number of years. Because of some real and potential problems associated with these peptide carriers, such as instability due to various endogenous peptidases, uncertain in vivo delivery efficiency, potential neurotoxicity and immunogenicity, an urgent need exists for the development of efficient, non-peptide molecular carriers. This review briefly summarizes the structural characteristics and the delivery properties of the newly developed non-peptide carriers, in particular the ones developed in the author's laboratory, together with their potential as delivery vectors for poorly bioavailable drugs including small molecules, proteins, and nucleotides.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890027     DOI: 10.1016/j.ijpharm.2007.08.016

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  6 in total

1.  Cooperative, heparan sulfate-dependent cellular uptake of dimeric guanidinoglycosides.

Authors:  Andrew V Dix; Lucile Fischer; Stéphane Sarrazin; Christopher P H Redgate; Jeffrey D Esko; Yitzhak Tor
Journal:  Chembiochem       Date:  2010-11-02       Impact factor: 3.164

2.  Tat-Mediated Peptide Intervention in Analgesia and Anesthesia.

Authors:  Feng Tao; Roger A Johns
Journal:  Drug Dev Res       Date:  2010-04-01       Impact factor: 4.360

3.  Tracking T-cells in vivo with a new nano-sized MRI contrast agent.

Authors:  Li Liu; Qing Ye; Yijen Wu; Wen-Yuan Hsieh; Chih-Lung Chen; Hsin-Hsin Shen; Shian-Jy Wang; Haosen Zhang; T Kevin Hitchens; Chien Ho
Journal:  Nanomedicine       Date:  2012-03-07       Impact factor: 5.307

4.  Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles.

Authors:  Bader B Alsulays; Md Khalid Anwer; Gamal A Soliman; Sultan M Alshehri; El-Sayed Khafagy
Journal:  Int J Nanomedicine       Date:  2019-11-25

5.  T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein.

Authors:  Julien Laurent; Cedric Touvrey; Silke Gillessen; Magali Joffraud; Manuela Vicari; Caroline Bertrand; Stefano Ongarello; Bernd Liedert; Elisa Gallerani; Joachim Beck; Aurelius Omlin; Cristiana Sessa; Sonia Quaratino; Roger Stupp; Ulrike S Gnad-Vogt; Daniel E Speiser
Journal:  J Transl Med       Date:  2013-01-07       Impact factor: 5.531

6.  Regulation of in vivo behavior of TAT-modified liposome by associated protein corona and avidity to tumor cells.

Authors:  Mohamadreza Amin; Mahsa Bagheri; Mercedeh Mansourian; Mahmoud Reza Jaafari; Timo Lm Ten Hagen
Journal:  Int J Nanomedicine       Date:  2018-11-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.